Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre studyKim Linton, Julie M. Vose, Hervé Tilly et al.|The Lancet Haematology|2024Cited by 134
Glycolytic Phenotype and AMP Kinase Modify the Pathologic Response of Tumor Xenografts to VEGF NeutralizationGiorgia Nardo, Stefano Indraccolo, Elena Favaro et al.|Cancer Research|2011Cited by 74
Hypoxia Inducible Factor-1α Inactivation Unveils a Link between Tumor Cell Metabolism and Hypoxia-Induced Cell DeathElena Favaro, Stefano Indraccolo|American Journal Of Pathology|2008Cited by 45
Epcoritamab SC Monotherapy Leads to Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: First Data Disclosure from the Epcore NHL-1 Follicular Lymphoma Dose-Expansion CohortKim Linton, Catherine Thiéblemont, Wojciech Jurczak et al.|Blood|2023Cited by 38